Elbers Paul W G, Ozdemir Alaattin, van Iterson Mat, van Dongen Eric P A, Ince Can
Department of Physiology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
J Cardiothorac Vasc Anesth. 2009 Feb;23(1):95-101. doi: 10.1053/j.jvca.2008.09.013. Epub 2008 Dec 5.
It has become possible to image the human microcirculation at the bedside using sidestream dark field (SDF) imaging. This may help the clinician when correlation between global and microvascular hemodynamics may not be straightforward. Ketanserin, a serotonin and alpha-1 adrenoceptor antagonist, is used in some countries to treat elevated blood pressure after extracorporeal circulation. This might hamper microcirculatory perfusion. Conversely, it is also conceivable that microcirculatory flow is maintained or improved as a result of flow redistribution. In order to introduce SDF imaging in cardiac anesthesia, the authors set out to directly observe the sublingual microcirculation in this setting.
An observational study.
A large teaching hospital.
Mechanically ventilated patients with elevated arterial blood pressure immediately after extracorporeal circulation (ECC).
An intravenous bolus of ketanserin, 0.15 mg/kg.
Five minutes before and 10 minutes after ketanserin administration, global hemodynamic variables were recorded. In addition, the authors used SDF imaging to record video clips of the microcirculation. Analysis of these allowed for quantification of microvascular hemodynamics including determination of perfused vessel density (PVD) and microcirculatory flow index (MFI). After ketanserin administration, there was a significant reduction in systolic arterial blood pressure (129 +/- 9 to 100 +/- 15 mmHg, p = 0.0001). At the level of the microcirculation, the mean MFI did not change significantly for small (diameter <20 microm, 2.79 [interquartile range, 1.38-3] to 2.38 [1.88-2.75], p = 0.62) or large (diameter >20 microm, 2.83 [1.4-3] to 2.67 [0.35-2.84] p = 1.0) vessels. There was a significant increase in mean PVD for large vessels (1.23 +/- 0.63 to 1.70 +/- 79 mm(-1), p = 0.017) but not for small vessels (5.59 +/- 2.60 to 5.87 +/- 1.22 mm(-1), p = 0.72) where red blood cell flow was maintained.
SDF imaging clearly showed a discrepancy between global and microvascular hemodynamics after the administration of ketanserin for elevated blood pressure after ECC. Ketanserin effectively lowers arterial blood pressure. However, capillary perfusion is maintained at a steady value. Both effects may be explained by an increase in shunting in the larger vessels of the microcirculation.
利用侧流暗视野(SDF)成像技术在床边对人体微循环进行成像已成为可能。当整体血流动力学与微血管血流动力学之间的相关性不直接时,这可能对临床医生有所帮助。酮色林是一种5-羟色胺和α-1肾上腺素能受体拮抗剂,在一些国家用于治疗体外循环后的血压升高。这可能会妨碍微循环灌注。相反,也可以想象,由于血流重新分布,微循环血流得以维持或改善。为了将SDF成像引入心脏麻醉领域,作者着手在此环境下直接观察舌下微循环。
一项观察性研究。
一家大型教学医院。
体外循环(ECC)后立即出现动脉血压升高的机械通气患者。
静脉推注0.15mg/kg酮色林。
在给予酮色林前5分钟和给药后10分钟,记录整体血流动力学变量。此外,作者使用SDF成像技术记录微循环的视频片段。通过对这些视频片段的分析,可以对微血管血流动力学进行量化,包括确定灌注血管密度(PVD)和微循环血流指数(MFI)。给予酮色林后,收缩压显著降低(从129±9mmHg降至100±15mmHg,p = 0.0001)。在微循环水平,小血管(直径<20微米,从2.79[四分位间距,1.38 - 3]降至2.38[1.88 - 2.75],p = 0.62)和大血管(直径>20微米,从2.83[1.4 - 3]降至2.67[0.35 - 2.84],p = 1.0)的平均MFI均无显著变化。大血管的平均PVD显著增加(从1.23±0.63增至1.70±79mm⁻¹,p = 0.017),而小血管(从5.59±2.60增至5.87±1.22mm⁻¹,p = 0.72)的PVD未显著增加,其中红细胞血流得以维持。
SDF成像清楚地显示了在ECC后使用酮色林治疗血压升高后整体血流动力学与微血管血流动力学之间的差异。酮色林有效地降低了动脉血压。然而,毛细血管灌注维持在稳定值。这两种效应都可以通过微循环较大血管中分流增加来解释。